These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11552901)

  • 21. The steroid resistance of Crohn's disease.
    Mingrone G; DeGaetano A; Pugeat M; Capristo E; Greco AV; Gasbarrini G
    J Investig Med; 1999 Jul; 47(6):319-25. PubMed ID: 10431487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.
    Mantzaris GJ; Christidou A; Sfakianakis M; Roussos A; Koilakou S; Petraki K; Polyzou P
    Inflamm Bowel Dis; 2009 Mar; 15(3):375-82. PubMed ID: 19009634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.
    Hinterleitner TA; Petritsch W; Aichbichler B; Fickert P; Ranner G; Krejs GJ
    Z Gastroenterol; 1997 Aug; 35(8):603-8. PubMed ID: 9297775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study.
    Valentine JF; Fedorak RN; Feagan B; Fredlund P; Schmitt R; Ni P; Humphries TJ
    Gut; 2009 Oct; 58(10):1354-62. PubMed ID: 19505878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?
    Malchow HA
    J Clin Gastroenterol; 1997 Dec; 25(4):653-8. PubMed ID: 9451682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease.
    Yacyshyn BR; Barish C; Goff J; Dalke D; Gaspari M; Yu R; Tami J; Dorr FA; Sewell KL
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1761-70. PubMed ID: 12269969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease.
    Kamm MA; Hanauer SB; Panaccione R; Colombel JF; Sandborn WJ; Pollack PF; Zhou Q; Robinson AM
    Aliment Pharmacol Ther; 2011 Aug; 34(3):306-17. PubMed ID: 21645018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-Year Outcomes After Exclusive Enteral Nutrition Induction Are Superior to Corticosteroids in Pediatric Crohn's Disease Treated Early with Thiopurines.
    Grover Z; Lewindon P
    Dig Dis Sci; 2015 Oct; 60(10):3069-74. PubMed ID: 26038093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.
    Campieri M; Ferguson A; Doe W; Persson T; Nilsson LG
    Gut; 1997 Aug; 41(2):209-14. PubMed ID: 9301500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease.
    Cortot A; Colombel JF; Rutgeerts P; Lauritsen K; Malchow H; Hämling J; Winter T; Van Gossum A ; Persson T; Pettersson E
    Gut; 2001 Feb; 48(2):186-90. PubMed ID: 11156638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.
    González-Huix F; de León R; Fernández-Bañares F; Esteve M; Cabré E; Acero D; Abad-Lacruz A; Figa M; Guilera M; Planas R
    Gut; 1993 Jun; 34(6):778-82. PubMed ID: 8314510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of an intravenous steroid regimen in the treatment of acute Crohn's disease.
    Shepherd HA; Barr GD; Jewell DP
    J Clin Gastroenterol; 1986 Apr; 8(2):154-9. PubMed ID: 3745849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beclomethasone dipropionate in Crohn's ileitis: a randomised, double-blind trial.
    Prantera C; Rizzi M; Cottone M; Casa A; Annese V; Sturniolo GC; Marconi S; Lochs H
    Dig Liver Dis; 2011 Jun; 43(6):459-64. PubMed ID: 21215714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW; Bickston SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythrocytes-mediated delivery of dexamethasone in steroid-dependent IBD patients-a pilot uncontrolled study.
    Annese V; Latiano A; Rossi L; Lombardi G; Dallapiccola B; Serafini S; Damonte G; Andriulli A; Magnani M
    Am J Gastroenterol; 2005 Jun; 100(6):1370-5. PubMed ID: 15929772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cutaneo-systemic papulosclerotic mucinosis (scleromyxedema): remission after extracorporeal photochemotherapy and corticoid bolus].
    D'Incan M; Franck F; Kanold J; Bacin F; Achin R; Beyvin AJ; Demeocq F; Souteyrand P
    Ann Dermatol Venereol; 2001 Jan; 128(1):38-41. PubMed ID: 11226899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine for induction of remission in Crohn's disease.
    McDonald JW; Feagan BG; Jewell D; Brynskov J; Stange EF; Macdonald JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000297. PubMed ID: 15846602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
    Feagan BG; Sandborn WJ; Baker JP; Cominelli F; Sutherland LR; Elson CO; Salzberg BA; Archambault A; Bernstein CN; Lichtenstein GR; Heath PK; Cameron S; Hanauer SB
    Aliment Pharmacol Ther; 2005 Feb; 21(4):373-84. PubMed ID: 15709987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.